Bionano Genomics, Inc.
BNGO
$4.00
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -112.02M | -135.78M | -204.10M | -226.79M | -232.49M |
| Total Depreciation and Amortization | 14.23M | 15.42M | 13.42M | 13.73M | 13.91M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 24.47M | 32.28M | 89.73M | 98.31M | 108.17M |
| Change in Net Operating Assets | 4.40M | -4.12M | -4.23M | -6.14M | -14.77M |
| Cash from Operations | -68.92M | -92.20M | -105.18M | -120.90M | -125.18M |
| Capital Expenditure | -103.00K | -848.00K | -923.00K | -1.36M | -1.69M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 96.00K | 96.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 73.94M | 16.32M | 55.19M | 56.48M | 25.75M |
| Cash from Investing | 73.84M | 15.47M | 54.27M | 55.22M | 24.16M |
| Total Debt Issued | 18.00M | 98.00M | 98.00M | 80.00M | 80.00M |
| Total Debt Repaid | -66.06M | -73.06M | -70.05M | -45.71M | -9.05M |
| Issuance of Common Stock | 44.45M | 49.03M | 51.84M | 58.02M | 57.83M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.08M | -23.06M | -22.31M | -14.97M | -14.97M |
| Cash from Financing | -13.69M | 50.91M | 57.48M | 77.34M | 113.82M |
| Foreign Exchange rate Adjustments | -7.00K | 45.00K | 11.00K | 3.00K | 65.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.78M | -25.77M | 6.58M | 11.66M | 12.86M |